Two years after officially legalizing medical cannabis, Uganda exported its first grams of medical cannabis to the UK.
Via the German company Cantourage and its British subsidiary, the Israeli company Together Pharma, a producer of medical cannabis in Uganda, exported an undisclosed quantity of medical cannabis for the Cantourage Clinic network of clinics.
Cantourage UK will thus offer two medical cannabis flowers with a high THC content and non-irradiated: Glueberry OG® (Gorilla Glue x OG Kush x Blueberry, 17% THC) and Power Plant (19% THC).
To our knowledge, Together Pharma is today the only company cultivating medical cannabis in Uganda despite many requests. His Ugandan farm spans around 30,000 m² of greenhouses and has a reported total production capacity of over 15 tonnes per year.
Together Pharma currently mainly supplies Israel with medical cannabis and made its first export to Germany at the start of the year, already with Cantourage, for an undisclosed quantity.
Niall Ivers, COO of Cantourage UK, said in a statement: “We are delighted to extend our successful partnership with Together Pharma to the UK. Together Pharma is a leader in the Israeli domestic market, with extensive knowledge and international experience in delivering high quality, high value medicines to patients. We are confident that the introduction of these first two varieties will help build a sustainable ecosystem for UK patients. »
Nir Sosinsky, Managing Director of Together Pharma, added: “The extension of our partnership with Cantourage UK is extremely exciting for Together Pharma and is another step in expanding our global reach. It strengthens our position in the UK and Europe, while supporting our commitment to Uganda’s cannabis industry, which holds great potential for the country. The UK is an extremely important market for us. We are pleased that our medical grade cannabis flowers are made available by Cantourage UK and Cantourage Clinic, enabling a reliable supply to benefit patients across the country. »